Chronic cough, defined as a cough lasting more than eight weeks, is a common yet challenging condition to manage in clinical practice. It often leads to significant morbidity, affecting patients' quality of life and causing considerable diagnostic and therapeutic dilemmas for clinicians.
Chronic cough is typically associated with three primary etiologies: asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS). These conditions often coexist, complicating diagnosis and management. The pathophysiology of chronic cough involves a complex interplay between the cough reflex pathway and various triggers, leading to hypersensitivity and hyperresponsiveness of the cough reflex.
An effective diagnostic approach begins with a thorough clinical history and physical examination. This is followed by initial testing to rule out common causes, such as chest radiography for suspected lung disease and spirometry for asthma. If these tests are inconclusive, further investigations may include high-resolution computed tomography, bronchoscopy, or esophageal pH monitoring for GERD. Empirical treatment trials can also provide diagnostic clues.
Management of chronic cough focuses on treating the underlying cause. For asthma, inhaled corticosteroids are first-line therapy. Proton pump inhibitors are used for GERD, and antihistamines or nasal steroids for UACS. In refractory cases, neuromodulators like gabapentin or amitriptyline can be considered to reduce cough reflex sensitivity. Patient education and reassurance are vital components of management.
Chronic cough is a complex condition requiring a comprehensive and systematic approach for effective diagnosis and management. Understanding the common etiologies, pathophysiology, and employing a stepwise diagnostic approach can aid in identifying the underlying cause. Tailoring the treatment to the identified cause, along with patient education, can significantly improve outcomes and patient satisfaction.
1.
On all CAR-T products, the FDA is calling for a new boxed warning.
2.
Video: Liver transplant for patients with advanced colorectal cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Healthcare AI, Meant to Save Money, Turns Out to Require a Lot of Expensive Humans
5.
Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
RIBOTAC Therapy for Oncogenic RNA: A Paradigm Shift in Targeted Cancer Treatment
3.
Monitoring Delayed Toxicity of Antibody Therapies
4.
Emerging Therapies Through Immune-Engineered Blood Cell Manufacturing
5.
What You Need To Know About Secondary Polycythemia: Treatment & Symptoms
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
2.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation